MALIGNANT GERM CELL TUMOR
|
ALTERNATE NAMES |
Pediatric Malignant Germ Cell Tumor; Adult Malignant Germ Cell Tumor
|
DESCRIPTION
|
Malignant Germ Cell Tumors (GCT) are malignant tumors that are formed by immature cells that begin in the reproductive
cells of the testes or ovaries. These germ cells travel into the pelvis as ovarian
cells or into the scrotal sac as testicular cells. These cells metastasize to other
parts of the body and most commonly spread to the lungs, liver, lymph nodes, and central
nervous system.
Adult germ cell tumors are usually in the testes or ovaries. There are germ cell tumors
that grow outside of the gonads (very rare). These cells may grow in any location
but generally settle in the brain (brain germ cell tumors), chest (chest germ cell
tumors), or abdomen (abdominal germ cell tumors). Germ cell tumors in children usually
form in the gonads, but can migrate to other areas. The exact cause of malignant GCT
is unknown.
|
DIAGNOSTIC TESTING, PHYSICAL FINDINGS, AND
ICD-9-CM/ICD-10-CM
CODING
|
Diagnostic testing: Biopsy and imaging studies
Physical findings: Physical examination of malignant GCT depend on the size and location of the tumor.
Symptoms of malignant GCTs depend on the size and location of the tumor.
Mid chest GCT may cause:
Lower back GCTs may present as a mass in the lower abdomen or buttocks.
Back of the abdomen GCTs may cause back pain or kidney problems and can sometimes
be felt during a physical examination.
GCTs that occur in the brain interfere with the flow of fluid around the brain and
spinal cord with symptoms of:
-
-
-
-
-
-
-
•
Uncontrolled eye movements; and
-
ICD-9: 183.00; 186.00
ICD-10: C56, C62
|
PROGRESSION
|
The prognosis for malignant germ cell tumors with distant or recurrent metastasis
is poor. Congenital abnormalities affecting the central nervous system including spine,
genitals, and urinary tract increase the risk for developing pediatric germ cell tumor
malignancy, although these tumors are still extremely rare in children. Adult GCT
generally occurs between 30- 40 years of age.
|
TREATMENT
|
Treatment for malignant GCT depends on the type of tumor, the stage at diagnosis,
and the age of the affected person. The primary treatment of most GCTs involves surgical
removal of the tumor. Tumors with distant metastasis or recurrent following debulking
surgery are treated with chemotherapy or radiation.
|
SUGGESTED PROGRAMMATIC ASSESSMENT*
|
Suggested MER for Evaluation:
-
•
Clinical history and examination that describes the diagnostic features of the impairment;
-
•
Pathology report of biopsy specimen; and
-
|
Suggested Listings for Evaluation:
|
DETERMINATION
|
LISTING
|
REMARKS
|
Meets
|
13.23 E 2
|
Listing level severity must be documented.
|
13.25
|
Listing level severity must be documented. |
113.03
|
Listing level severity must be documented. |
Equals |
|
|
* Adjudicators may, at their discretion, use the Medical Evidence of Record or the
listings suggested to evaluate the claim. However, the decision to allow or deny the
claim rests with the adjudicator.
|